The first FDA-approved treatment for canine Addison’s disease (hypoadrenocorticism). For use as replacement therapy for the mineralocorticoid deficit in dogs with primary adrenocortical insufficiency.
Percorten-V (desoxycorticosterone pivalate injectable suspension) has a proven history of delivering life-saving results. Percorten-V you can give your clients a simple way to manage canine Addison’s disease.
Med-Vet International does not sell pharmaceuticals outside of the United States. The following states are restricted from purchasing pharmaceuticals and controlled substances: AK, AS, CA, FL, GU, IA, KS, MD, MN, IN, NE, NV, ND, MP, OR, PR, VI, WI, WY.